PeptiDream Inc. and PDRadiopharma Inc. (PeptiDream Group)
Climate Impact & Sustainability Data (2020, 2021, 2023, FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma))
Reporting Period: 2020
Environmental Metrics
Total Carbon Emissions:1381 tCO2e/year
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:1381 tCO2e/year
Scope 3 Emissions:236 tCO2e/year
Total Energy Consumption:2946 MWh/year
Water Consumption:5312 m3/year
Waste Generated:102.4 tons/year
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Achieved S-Certification, the highest rank of the CASBEE environmental performance assessment for its new headquarters and laboratory.
- Reduced CO2 emissions (Scope 1+2) to 1,381 tons in FY2020 (9.2 tons per employee).
- Business-related waste recycling rate of approximately 100%.
- Adopted an electricity supplier that proactively promotes renewable energy since August 2018.
Social Achievements
- Female employee ratio of 38% (exceeds the pharmaceutical industry average).
- 100% of female employees have taken childcare leave in the past eight years, with a 100% return and six-year retention rate.
- Employee turnover rate of 3.2% (well below the industry average).
- Actively participates in local community events and educational/academic activities.
Governance Achievements
- Established an Auditing Committee with four independent external directors with voting rights.
- Ratio of independent external directors is 57%.
- Proactive and fair disclosure of corporate information.
Climate Goals & Targets
Short-term Goals:
- Become "carbon neutral" in operations by 2026.
Environmental Challenges
- Increasing water consumption during winter months due to humidifier use.
- Managing Scope 3 emissions.
Mitigation Strategies
- Considering more efficient methods for water usage during winter.
- Implementing measures to reduce Scope 3 emissions (details not specified in report).
Supply Chain Management
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: TCFD
Certifications: CASBEE S-Certification
Reporting Period: 2021
Environmental Metrics
Total Carbon Emissions:7.72 tCO2e/year (2021); 0 tCO2e/year (2022)
Renewable Energy Share:100% (2022)
ESG Focus Areas
- CO2 emission reduction and climate change
- Reducing waste
- Effective use of water resources and prevention of water pollution
- Diversification of core human resources
- Respect for diversity and creation of decent working environment
- Respect for human rights and observance of occupational health and safety
- Dialogue with shareholders, investors, and the broader community
- Corporate governance
- Compliance and risk management
- Contribution to local communities
Environmental Achievements
- Reduced 1.49 t CO2 (YoY) for CO2 emissions per employee (Scope1+2)
- Switched to virtually CO2-free electricity across business operations in January 2022 (four years ahead of schedule)
Social Achievements
- Appointed a female director in 2021
- Established targets for 2030 for workforce diversity (at least 50% doctorate holders, 30% female managers, 30% foreign employees or employees with overseas work experience, 30% employees in their 20s/30s)
- Supporting Japan's leading wheelchair rugby athletes
- Implemented onboarding program to promote mutual understanding between organizations
- Held monthly townhall meetings for all employees
Governance Achievements
- Established the Sustainability and Governance Committee in 2021
- Appointed an Independent External Director as Chairman of the Board of Directors
- Amended Articles of Incorporation to allow the Chairman of the Board of Directors to be an independent external director
- Conducted a scenario analysis on climate-related risks and opportunities in line with TCFD recommendations
Climate Goals & Targets
Long-term Goals:
- Become a Drug Discovery Powerhouse in the next decade
Medium-term Goals:
- Targets for 2030 for workforce diversity (at least 50% doctorate holders, 30% female managers, 30% foreign employees or employees with overseas work experience, 30% employees in their 20s/30s)
Short-term Goals:
- Achieve carbon neutral across business operations by 2026 (achieved in 2022)
Environmental Challenges
- Concentration of personnel and facilities at a single site, posing risk from natural disasters (flooding)
- Risk of infectious diseases and cyberattacks
Mitigation Strategies
- Emergency power supply installed, evacuation space designated, three days' worth of food and water stockpiled, regular disaster drills conducted
- Information Security Manager appointed, measures to prevent information leakage implemented, external expert utilized for incident response
Supply Chain Management
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Flooding
Opportunities
- Increased need for research and development of infectious diseases
Reporting Standards
Frameworks Used: TCFD
Certifications: CASBEE S rating (headquarters and laboratories)
UN Sustainable Development Goals
- SDG 3: Good Health and Well-being
Contribution through research activities
Awards & Recognition
- TOP-RATED ESG PERFORMER 2022 from Sustainalytics
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Climate change/CO2 emission reduction
- Waste reduction
- Biodiversity conservation
- Addressing unmet medical needs through the discovery of transformational medicines
- Responsible sourcing/Stable product supply
- Community relations
- Cultivating a culture of innovation/Ensuring diversity in core human resources
- Respecting human rights/Occupational health and safety
- Corporate governance
- Compliance and risk management
- Stakeholder engagement
Environmental Achievements
- Achieved carbon neutrality across PeptiDream operations for 3 consecutive years
- PDRadiopharma decided to switch to renewable energy
- Set group-wide carbon emission reduction target for SBT accreditation
Social Achievements
- Reformed HR system based on newly defined Values & Behaviors
- Visualization of employee engagement
- Continued efforts to enhance cybersecurity
- Formulated basic policies and personnel requirements for CEO succession plan
- BPC measures against large-scale natural disasters
Governance Achievements
- Strengthened supervisory by independent Outside Directors and the Auditing Committee
- Selected as an index constituent of the FTSE4Good Index Series and FTSE Blossom Japan Index
- Achieved A- rating from CDP for the second consecutive year
Climate Goals & Targets
Medium-term Goals:
- Reduce Scope 1+2 emissions by 100% by 2030 (vs 2023 baseline)
- Reduce Scope 3 CO2 emissions by 20% by 2030 (vs 2023 baseline)
Environmental Challenges
- Challenges to attract and retain top talent due to labor shortages in Japan
- Intensifying conflicts between or within nations, political, economic and social decoupling and security crisis
Mitigation Strategies
- Strengthening recruitment competitiveness and securing human resources through improving employee engagement; responding to societal changes such as rising wage levels and diversifying work styles
- Diversifying the supply of raw materials to multiple regions and companies
Supply Chain Management
Supplier Audits: 100% response rate for major raw material suppliers
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Temporary suspension of business operation due to damage to facilities caused by natural disasters and restrictions on the supply of various infrastructures
Transition Risks
- Increased costs due to the introduction of carbon taxes
Reporting Standards
Frameworks Used: GRI, TCFD
Reporting Period: FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)
Environmental Metrics
Total Carbon Emissions:0 tCO2e (Scope 1+2) in FY2022
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:100% of electricity from renewable sources in 2022
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Climate Change/CO2 Emission Reduction
- Waste Reduction
- Biodiversity Conservation
- Responsible Sourcing/Stable Product Supply
- Community Relations
- Corporate Governance
- Compliance and Risk Management
- Cultivating a culture of innovation/Ensuring diversity in core human resources
- Respecting human rights/Occupational health and safety
- Addressing unmet medical needs through the discovery of transformational medicines
- Stakeholder Engagement
Environmental Achievements
- Achieved carbon neutrality across business operations (Scope 1+2) in 2022
- Reduced electricity consumption per employee by approximately 12% year-on-year by optimization of power management
Social Achievements
- Conducted first diversity and inclusion training
- 100% of female employees and 75% of male employees took childcare leave; 100% return rate for both
- Conducted first sustainability procurement survey to major suppliers and collected 100% of survey responses
Governance Achievements
- Strengthened corporate governance to achieve higher standards than those required in Prime Market level
- Established Compliance Risk Management Committee to strengthen risk management
- Appointed outside Director as Chairperson of the Board
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Potential business interruption due to natural disasters (flooding) affecting facilities and infrastructure in Tonomachi, Kawasaki City.
- Cybersecurity threats
Mitigation Strategies
- Emergency power supply installed, R&D equipment on multiple floors, three days' worth of food and water stockpiled for employees.
- 24/7 security monitoring, server-less systems, strict endpoint management, and regular cybersecurity awareness training for employees.
Supply Chain Management
Supplier Audits: 100% response rate to sustainability procurement survey in 2022
Responsible Procurement
- Sustainability procurement survey based on GCNJ questionnaire; Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather, flooding (Tama River)
Transition Risks
- Regulatory changes, market shifts
Opportunities
- Increased demand for new drug co-development due to climate change-related health issues
Reporting Standards
Frameworks Used: TCFD
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- A- (A minus) rating from CDP’s 2022 Climate Change Report